Neurocrine's bid to save schizophrenia prospect fails
ESMO: Moderna’s mRNA solid tumour vaccine shows early promise
FDA approves Roche’s Tecentriq Hybreza for cancer
Three biotechs raise $700M in rare burst of IPO activity
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*
ESMO: Moderna’s mRNA solid tumour vaccine shows early promise
FDA approves Roche’s Tecentriq Hybreza for cancer
Three biotechs raise $700M in rare burst of IPO activity
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*